Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Authors
Keywords
Yes-associated protein 1, Cyclin E, TEAD4, Bladder cancer, Metformin
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-27
DOI
10.1186/s13046-019-1346-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity
- (2018) Xuesong Yuan et al. BIOMEDICINE & PHARMACOTHERAPY
- Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
- (2018) Eric Ciamporcero et al. FREE RADICAL BIOLOGY AND MEDICINE
- Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2
- (2018) Mingkun Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies
- (2018) Joseph A. Caruso et al. CANCER RESEARCH
- YAP regulates ALDH1A1 expression and stem cell property of bladder cancer cells
- (2018) Aiyue Zhao et al. OncoTargets and Therapy
- Metformin targets gastric cancer stem cells
- (2017) Sarah Courtois et al. EUROPEAN JOURNAL OF CANCER
- AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms
- (2016) Antero Salminen et al. BIOGERONTOLOGY
- Cyclin E as a potential therapeutic target in high grade serous ovarian cancer
- (2016) J. Kanska et al. GYNECOLOGIC ONCOLOGY
- Impact of Glycemic Control and Metformin Use on the Recurrence and Progression of Non-Muscle Invasive Bladder Cancer in Patients with Diabetes Mellitus
- (2016) Ji Hoon Ahn et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27
- (2016) Stavros Kopsiaftis et al. MOLECULAR CANCER RESEARCH
- Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
- (2016) Yu Tian et al. Oncotarget
- Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell
- (2016) Liang Dong et al. Journal of Cancer
- Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
- (2016) Mei Peng et al. Scientific Reports
- Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma
- (2015) B. H. Sohn et al. CLINICAL CANCER RESEARCH
- Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways
- (2015) Qi Pan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
- (2015) Jung-Soon Mo et al. NATURE CELL BIOLOGY
- YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
- (2015) E Ciamporcero et al. ONCOGENE
- G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma
- (2015) Feng Li et al. PLoS One
- In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin
- (2015) DONG WANG et al. Oncology Letters
- YAP is a critical oncogene in human cholangiocarcinoma
- (2015) Tiemin Pei et al. Oncotarget
- Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
- (2014) Chin-Hsiao Tseng ACTA DIABETOLOGICA
- Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP
- (2014) Tao Zhang et al. ANTI-CANCER DRUGS
- The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease
- (2014) Y.-P. Fu et al. CANCER RESEARCH
- Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer
- (2014) Yi-Jun Shen et al. CANCER SCIENCE
- The Hippo signaling pathway in stem cell biology and cancer
- (2014) J.-S. Mo et al. EMBO REPORTS
- Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein
- (2014) Michael DeRan et al. Cell Reports
- Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
- (2013) Jian-Ye Liu et al. BMC CANCER
- AMPK Activation by Oncogenesis Is Required to Maintain Cancer Cell Proliferation in Astrocytic Tumors
- (2013) M. Rios et al. CANCER RESEARCH
- The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo
- (2013) Tao Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer
- (2012) Said Akli et al. CELL CYCLE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Meta-analysis for cyclin E in lung cancer survival
- (2012) Li-nian Huang et al. CLINICA CHIMICA ACTA
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
- (2012) M A Pierotti et al. ONCOGENE
- Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells
- (2012) Caroline H. Diep et al. PLoS One
- Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
- (2012) W-Y Shi et al. Cell Death & Disease
- Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
- (2011) W. Kang et al. CLINICAL CANCER RESEARCH
- Cyclin E Transgenic Mice: Discovery Tools for Lung Cancer Biology, Therapy, and Prevention
- (2010) S. J. Freemantle et al. Cancer Prevention Research
- Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
- (2010) Yang Wang et al. CANCER SCIENCE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Structural insights into the YAP and TEAD complex
- (2010) Z. Li et al. GENES & DEVELOPMENT
- Cyclins and their related proteins in pituitary tumourigenesis
- (2010) Mădălina Muşat et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
- (2009) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now